Skip to main content

Table 1 The laboratory data, initial and 2 years after

From: Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report

Hematology (initial)

Biochemistry (initial)

WBC

18,100

/μL

TP

6.9

g/dL

CEA

2.6

ng/mL

Neut

69.5

%

Alb

2.8

g/dL

SCC

0.9

ng/mL

Eos

16

%

AST

9

U/L

NSE

10.3

ng/mL

Lym

11

%

ALT

16

U/L

ProGRP

33.9

pg/mL

Hb

8.9

g/dL

LDH

192

U/L

CYFRA

1.6

ng/mL

Ht

27.2

%

ALP

522

U/L

CA19–9

5

U/mL

MCV

86.3

μm3

γ-GTP

79

U/L

sIL-2R

10,252

U/mL

MCHC

32.7

%

CK

16

U/L

HTLV-1 antibody

< 16

times

Plt

375,000

/μL

Na

138

mEq/L

T-SPOT®

(−)

 

ESR

136

mm/h

K

4.5

mEq/L

QuantiFERON®

< 0.05

 
   

Cl

102

mEq/L

  

undeterminate

(2 years after)

 

BUN

23

mg/dL

Capillia MAC IgA®

(−)

 
   

CRE

0.93

mg/dL

IgG

1072

mg/dL

WBC

7400

/μL

Blood Sugar

106

mg/dL

IgA

144

mg/dL

Lym

20.4

%

CRP

7.56

mg/dL

IgM

61

mg/dL

CD4

30.7

%

PCT

0.43

ng/mL

HIV-1/2 antibodies

(−/−)

 

CD8

39.7

%

β-D glucan

< 2.4

pg/mL

   

CD4/CD8

0.8

    

PHA SI

528.4

 
  1. PCT procalcitonin, CEA carcinoembryonic antigen, SCC Squamous Cell Carcinoma, CYFRA cytokeratin 19 fragment, NSE nerve specific enolase, Pro GRP pro-gastrin releasing peptide, CA19–9 carbohydrate antigen 19–9, sIL-2R soluble interleukin-2 receptor, PHA SI the lymphocyte phytohemagglutinin (PHA) stimulation index